4-hydroxycyclophosphamide has been researched along with Vasculitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaisdell, J; Bridges, AS; Brouwer, KL; Dooley, MA; Falk, RJ; Frye, RF; Goldstein, JA; Hogan, SL; Hu, Y; Joy, MS; La, M; Wang, J | 1 |
1 trial(s) available for 4-hydroxycyclophosphamide and Vasculitis
| Article | Year |
|---|---|
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis.
Topics: Adult; Aged; Area Under Curve; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromatography, Liquid; Cyclophosphamide; Cytochrome P-450 CYP2B6; Female; Glomerulonephritis; Half-Life; Humans; Lupus Erythematosus, Systemic; Male; Mass Spectrometry; Middle Aged; Oxidoreductases, N-Demethylating; Polymorphism, Single Nucleotide; Serum Albumin; Vasculitis | 2012 |